Table 3.
Analyses of factors correlated with sAF (10–2 AU) (Pearson correlation test)
| Variable | r | p value |
|---|---|---|
| sAF (10–2AU) (PD + HD + Pre) | ||
| LVMI (g/m2,7) | 0.44 | 0.0001 |
| PWV/ht (m/s) | 0.24 | 0.03 |
| homocysteine (μmol/l) | 0.26 | 0.02 |
| SBP (mmHg) | 0.28 | 0.01 |
| DBP (mmHg) | 0.23 | 0.03 |
| P (mg/dl) | 0.46 | <0.0001 |
| CaxP (mg2/dl2) | 0.44 | <0.0001 |
| sAF (10–2AU) (PD + HD) | ||
| dial. treatment duration (months) | 0.46 | <0.0001 |
| P (mg/dl) | 0.33 | 0.03 |
| CaxP (mg2/dl2) | 0.32 | 0.03 |
| sAF (10–2AU) (Pre) | ||
| Creatinine clearance (ml/min/1.73 m2) | 0.42 | 0.0003 |
| sAF (10–2AU) (Control) | ||
| Ca (mg/dl) | 0.51 | 0.007 |
sAF skin autofluorescence, LVMI left ventricular mass index, PWV/ht pulse wave velocity indexed to height, SBP systolic blood pressure, DBP diastolic blood pressure